Federal health officials have revived a contested change to the way drug discounts reach hospitals and clinics that serve low-income patients, setting a start date of January 1, 2027. Under the revised 340B Rebate Model Pilot Program, participating drug manufacturers would no longer give eligible providers a discounted purchase price at the point of sale. Instead, providers would pay the full price up front and claim a rebate afterward.
The Health Resources and Services Administration released the revised pilot at the end of July, and the notice appeared in the Federal Register days later. Manufacturers that want to take part must submit rebate plans by August 24, with approvals expected about a month afterward.
